at Zacks.com (Dec 19, 2014)
Shares of Oncothyreon (ONTY) get a lift from a price target increase from JMP Securities. Analyst with the firm raise their PT to $14 from $8 - marking 125% upside potential. Shares +3.7% premarket.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Dec 15, 2014)
at Zacks.com (Nov 28, 2014)
at MarketWatch.com (Aug 18, 2014)
at MarketWatch.com (Dec 19, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs